Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

The package will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines, the company said